Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$82.37 - $107.29 $21.9 Million - $28.6 Million
266,200 Added 177.7%
416,000 $34.4 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $13 Million - $15.5 Million
126,600 Added 545.69%
149,800 $17 Million
Q2 2021

Aug 10, 2021

SELL
$83.84 - $104.76 $2.65 Million - $3.31 Million
-31,600 Reduced 57.66%
23,200 $2.4 Million
Q1 2021

May 14, 2021

SELL
$78.68 - $90.67 $4.64 Million - $5.35 Million
-59,000 Reduced 51.85%
54,800 $4.58 Million
Q4 2020

Feb 11, 2021

SELL
$71.69 - $91.23 $5.38 Million - $6.84 Million
-75,000 Reduced 39.72%
113,800 $10.4 Million
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $2.22 Million - $2.89 Million
33,000 Added 21.18%
188,800 $15.1 Million
Q2 2020

Aug 12, 2020

BUY
$57.54 - $76.95 $5.65 Million - $7.56 Million
98,200 Added 170.49%
155,800 $10.8 Million
Q1 2020

May 14, 2020

SELL
$52.41 - $81.0 $524,099 - $810,000
-10,000 Reduced 14.79%
57,600 $10.9 Million
Q4 2019

Feb 10, 2020

SELL
$71.7 - $82.09 $64,530 - $73,881
-900 Reduced 1.31%
67,600 $15.8 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $578,570 - $709,042
9,400 Added 15.91%
68,500 $15.1 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $55,740 - $64,410
-1,000 Reduced 1.66%
59,100 $10.9 Million
Q1 2019

May 14, 2019

SELL
$47.89 - $64.05 $431,010 - $576,450
-9,000 Reduced 13.02%
60,100 $11.5 Million
Q3 2018

Nov 13, 2018

BUY
$45.7 - $58.03 $918,570 - $1.17 Million
20,100 Added 41.02%
69,100 $12 Million
Q1 2018

May 11, 2018

SELL
$37.19 - $47.45 $111,570 - $142,350
-3,000 Reduced 5.77%
49,000 $6.84 Million
Q4 2017

Feb 09, 2018

SELL
$33.79 - $39.39 $878,540 - $1.02 Million
-26,000 Reduced 33.33%
52,000 $5.86 Million
Q3 2017

Nov 13, 2017

SELL
$36.29 - $38.83 $145,160 - $155,320
-4,000 Reduced 4.88%
78,000 $8.53 Million
Q2 2017

Aug 14, 2017

BUY
N/A
82,000
82,000 $9.7 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.